Does ERDAFITINIB Cause Product use issue? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product use issue have been filed in association with ERDAFITINIB (BALVERSA). This represents 1.2% of all adverse event reports for ERDAFITINIB.
13
Reports of Product use issue with ERDAFITINIB
1.2%
of all ERDAFITINIB reports
1
Deaths
9
Hospitalizations
How Dangerous Is Product use issue From ERDAFITINIB?
Of the 13 reports, 1 (7.7%) resulted in death, 9 (69.2%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERDAFITINIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ERDAFITINIB Cause?
Death (255)
Off label use (86)
Diarrhoea (75)
Stomatitis (58)
Fatigue (45)
Onycholysis (44)
Disease progression (41)
Dry mouth (41)
Nail disorder (40)
Hyperphosphataemia (39)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which ERDAFITINIB Alternatives Have Lower Product use issue Risk?
ERDAFITINIB vs ERENUMAB
ERDAFITINIB vs ERENUMAB-AOOE
ERDAFITINIB vs ERENUMAB\ERENUMAB-AOOE
ERDAFITINIB vs ERGOCALCIFEROL
ERDAFITINIB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL